Comprehensive pan-cancer analysis of DIMT1 reveals its prognostic significance and immune-associated characteristics with experimental validation in gastric cancer
Pan-cancer analyses revealed distinct genomic and epigenetic alteration patterns and demonstrated significant associations between DIMT1 expression and immune infiltration profiles, immune regulatory genes, and cancer-type-specific TMB/MSI characteristics in gastric cancer.
Abstract
Dimethyladenosine Transferase 1 (DIMT1) is an rRNA-modifying enzyme involved in ribosome biogenesis; however, its potential oncogenic relevance and immune-associated characteristics across human cancers remain incompletely understood. Here, we aimed to systematically characterize the biological and clinical significance of DIMT1 across malignancies.
A comprehensive pan-cancer analysis was performed by integrating transcriptomic, genomic, and epigenetic data from TCGA and GTEx datasets. DIMT1 expression patterns, prognostic significance, genomic alterations, DNA methylation characteristics, and associations with the tumor immune microenvironment were systematically evaluated using multiple bioinformatics approaches. Functional enrichment and drug sensitivity analyses were further conducted in gastric cancer. In addition, in vitro and in vivo experiments were performed to investigate the biological effects of DIMT1 depletion in gastric cancer models.
DIMT1 exhibited predominant nuclear localization and was aberrantly expressed across multiple cancer types. Elevated DIMT1 expression was associated with unfavorable survival outcomes in several malignancies. Pan-cancer analyses revealed distinct genomic and epigenetic alteration patterns and demonstrated significant associations between DIMT1 expression and immune infiltration profiles, immune regulatory genes, and cancer-type-specific TMB/MSI characteristics. In gastric cancer, DIMT1-associated genes were enriched in pathways related to RNA metabolism, cell-cycle regulation, and immune-related processes. Functional validation further demonstrated that DIMT1 silencing significantly inhibited gastric cancer cell proliferation, migration, and invasion in vitro and suppressed tumor growth in vivo.
Our study provides a comprehensive characterization of DIMT1 across human cancers and identifies DIMT1 as a potential prognostic and immune-associated biomarker. Experimental validation further supports its tumor-promoting role in gastric cancer, highlighting DIMT1 as a candidate target for future therapeutic investigation.
Tetratricopeptide repeat domain protein 39B (TTC39B) is a lipid metabolism–related gene recently implicated in cholesterol regulation. However, its clinical and biological relevance in human cancers remains undefined.
Based on multi-omics data from the Cancer Genome Atlas (TCGA) pan-cancer dataset represen...
Hui-Juan Yi, Yan Wang, Chen-Hao Zhao et al.· BMC Medical Genomics· 0 citations
Background Zinc finger CCCH-type protein 15 (ZC3H15) is a ribosome-associated eukaryotic protein involved in many biological processes, including gene expression regulation, translation, and immune modulation. Although ZC3H15 has been implicated in the development of certain tumors, its expression, functional relevance...
Bin Zhou, Jian Huang, Qi-Fei Tao et al.· Frontiers in Immunology· 0 citations
Background: Calcium/calmodulin-dependent protein kinase II alpha (CAMK2A) is a neuron-enriched kinase that plays essential roles in synaptic signaling and neuronal differentiation. However, its clinical significance and biological relevance in glioma remain incompletely understood. This study aimed to systematically ch...
Yi-Min Pan, Chang-Wu Wu, Jun Tan et al.· Biomedicines· 0 citations
ISG20L2 is aberrantly upregulated and associated with malignant biological features and immune-related characteristics in gastric cancer, supporting its potential role as a pro-oncogenic regulator and a candidate molecular indicator requiring further clinical validation.
Song Liang, Chuan-Jun Wang, Yong-Kang Liang et al.· Frontiers in Oncology· 0 citations
ABSTRACT Multiple public databases, including TCGA, GEO, and TARGET, were utilized to comprehensively analyze pyridoxal phosphatase (PDXP) expression profiles across 34 cancer types. We further explored the associations of PDXP expression with clinicopathological features, tumor immune microenvironment, genomic heterog...
Ying-Jian Hu, Xin-Zhu Zeng, Wei Cao et al.· Cancer Medicine· 0 citations
The apolipoprotein B mRNA-editing catalytic polypeptide-like (APOBEC) family comprises ten cytidine deaminases implicated in cancer mutagenesis, yet their broader biological significance remains incompletely understood. We performed an integrated pan-cancer analysis of all ten APOBEC family members across 9653 tumors f...
Sairos Ghniem, I. Georgakopoulos-Soares, A. Zaravinos· International Journal of Mol...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.